Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

NCT03012100

Conditions
Bilateral Breast Carcinoma, Breast Diseases, Breast Inflammatory Carcinoma, +18 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View Trial Details
Active, Not Recruiting

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

NCT06449222

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +7 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto, California, United States
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

NCT01273610

Conditions
Behavior, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • South Pasadena Cancer Center Pasadena, California, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

NCT05082259

Conditions
Advanced Cancer, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, United Kingdom
  • The Royal Marden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Breast Unit Sutton, United Kingdom
View Trial Details

Related conditions